Private Capital Group LLC Acquires 219 Shares of LHC Group, Inc. (LHCG)

Private Capital Group LLC raised its holdings in LHC Group, Inc. (NASDAQ:LHCG) by 24.4% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,116 shares of the health services provider’s stock after purchasing an additional 219 shares during the quarter. Private Capital Group LLC’s holdings in LHC Group were worth $124,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of LHCG. Norges Bank acquired a new position in LHC Group during the 4th quarter worth $51,535,000. FMR LLC lifted its holdings in LHC Group by 24.9% during the 4th quarter. FMR LLC now owns 1,123,833 shares of the health services provider’s stock worth $105,506,000 after buying an additional 224,124 shares during the last quarter. BlackRock Inc. lifted its holdings in LHC Group by 2.7% during the 4th quarter. BlackRock Inc. now owns 4,566,337 shares of the health services provider’s stock worth $428,687,000 after buying an additional 121,385 shares during the last quarter. Castleark Management LLC purchased a new stake in LHC Group during the 4th quarter worth about $9,047,000. Finally, Trillium Asset Management LLC lifted its holdings in LHC Group by 251.7% during the 4th quarter. Trillium Asset Management LLC now owns 77,350 shares of the health services provider’s stock worth $7,262,000 after buying an additional 55,359 shares during the last quarter. Institutional investors own 94.07% of the company’s stock.

In other LHC Group news, CEO Keith G. Myers sold 75,000 shares of the stock in a transaction on Friday, March 1st. The stock was sold at an average price of $108.53, for a total transaction of $8,139,750.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Donald Dwayne Stelly sold 448 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $120.00, for a total value of $53,760.00. Following the transaction, the chief operating officer now directly owns 91,252 shares in the company, valued at approximately $10,950,240. The disclosure for this sale can be found here. In the last quarter, insiders have sold 130,324 shares of company stock worth $14,222,700. 5.20% of the stock is owned by insiders.

A number of analysts have issued reports on LHCG shares. UBS Group set a $133.00 price target on LHC Group and gave the stock a “buy” rating in a report on Friday, May 10th. Jefferies Financial Group boosted their target price on LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, May 9th. BidaskClub raised LHC Group from a “hold” rating to a “buy” rating in a report on Tuesday, April 30th. SunTrust Banks boosted their target price on LHC Group to $130.00 and gave the company a “buy” rating in a report on Friday, March 1st. Finally, Barclays boosted their target price on LHC Group from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Thursday, March 21st. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $118.50.

NASDAQ LHCG traded up $0.25 on Wednesday, hitting $118.87. 192,085 shares of the company’s stock were exchanged, compared to its average volume of 259,736. The stock has a market capitalization of $3.74 billion, a price-to-earnings ratio of 33.48, a PEG ratio of 2.01 and a beta of 0.87. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21. LHC Group, Inc. has a fifty-two week low of $73.21 and a fifty-two week high of $122.20.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.08. The business had revenue of $502.59 million for the quarter, compared to analysts’ expectations of $511.16 million. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. Equities analysts forecast that LHC Group, Inc. will post 4.3 earnings per share for the current fiscal year.

WARNING: This piece was reported by Sundance Herald and is the sole property of of Sundance Herald. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://sundanceherald.com/2019/05/22/private-capital-group-llc-buys-219-shares-of-lhc-group-inc-lhcg.html.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Story: What is diluted earnings per share (Diluted EPS)?

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply